Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Updates in cytogenetics and molecular markers in MDS.

Current hematologic malignancy reports - 1 Jun 2011

Tiu Ramon V, Visconte Valeria, Traina Fabiola, Schwandt Anita, Maciejewski Jaroslaw P

Abstract excerpt

Myelodysplastic syndromes (MDS) are clonal hematologic neoplasms that can result in cytopenias and increase the risk of leukemic transformation. The disease is characterized by several recurrent cytogenetic defects, which can affect diagnosis, prognosis, and treatment. Metaphase cytogenetics (MC) is the gold standard in karyotypic analysis in hematology. Progress in molecular analysis, including additional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to Comparative Genomic Hybridization

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytogenetic Analysis

Share to Genetic Predisposition to Disease

Share to Karyotyping

Share to Myelodysplastic Syndromes

Share to Polymorphism, Single Nucleotide

Share to Prognosis

Source

Identifiers

PMID: 21340513
DOI: 10.1007/s11899-011-0081-2

Genes

ASXL1
CBL
IDH1
IDH2
TET2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Updates in cytogenetics and molecular markers in MDS.PMID 21340513Read ↗

Update on cytogenetic and molecular changes in myelodysplastic syndromes.Semantic proximity Read ↗

Cytogenetic and molecular abnormalities in myelodysplastic syndrome.Semantic proximity Read ↗

Myelodysplastic syndromes: Updates on Genomic Landscape, Molecular Subtypes, & Targeted Therapies.Semantic proximity Read ↗

The genetic basis and expanding role of molecular analysis in the diagnosis, prognosis, and therapeutic design for myelodysplastic syndromes.Semantic proximity Read ↗

The Use of Flow Cytometry in Myelodysplastic Syndromes: A ReviewSemantic proximity Read ↗

Unraveling the molecular pathophysiology of myelodysplastic syndromes.Semantic proximity Read ↗

Mutations of myelodysplastic syndromes (MDS): An update.Semantic proximity Read ↗

The genetics of the myelodysplastic syndromes: classical cytogenetics and recent molecular insights.Semantic proximity Read ↗

Integrating genetics and epigenetics in myelodysplastic syndromes: advances in pathogenesis and disease evolutionSemantic proximity Read ↗

Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview.Semantic proximity Read ↗

A Brief Overview of the Molecular Landscape of Myelodysplastic Neoplasms.Semantic proximity Read ↗

Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.